Adverse cutaneous drug reactions in patients with human immunodeficiency virus-1 infection
- 1 July 2000
- journal article
- review article
- Published by Elsevier in Clinics in Dermatology
- Vol. 18 (4) , 485-489
- https://doi.org/10.1016/s0738-081x(99)00144-3
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Acetylator Status and Tolerance of High‐Dose Trimethoprim‐Sulfamethoxazole Therapy Among Patients Infected with Human Immunodeficiency VirusClinical Infectious Diseases, 1997
- The effect of fluconazole and ketoconazole on the metabolism of sulphamethoxazolePublished by Wiley ,1996
- Adverse Events Associated with Trimethoprim-Sulfamethoxazole and Atovaquone during the Treatment of AIDS-Related Pneumocystis carinii PneumoniaThe Journal of Infectious Diseases, 1995
- Time-course of toxicity of reactive sulfonamide metabolitesToxicology, 1995
- Adverse cutaneous reactions to trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome and Pneumocystis carinii pneumoniaArchives of Dermatology, 1994
- Effect of Corticosteroids on the Incidence of Adverse Cutaneous Reactions to Trimethoprim-Sulfamethoxazole During Treatment of AIDS-Associated Pneumocystis carinii PneumoniaClinical Infectious Diseases, 1994
- In vitro cytotoxicity as a marker of hypersensitivity to sulphamethoxazole in patients with HIVClinical and Experimental Immunology, 1993
- Cutaneous Disease and Drug Reactions in HIV InfectionNew England Journal of Medicine, 1993
- Clinical and Laboratory Markers of Hypersensitivity to Trimethoprim-Sulfamethoxazole in Patients with Pneumocystis carinii Pneumonia and AIDSThe Journal of Infectious Diseases, 1993
- Nail and mucocutaneous hyperpigmentation with azidothymidine therapyJournal of the American Academy of Dermatology, 1990